Table 5.

Associations between participants’ characteristics and reported barriers to mifepristone provision (N=433)

Participant characteristics	Cost	Liability	Lack of prescriptions	Inadequate stock	Need for training	Lack of payment mechanisms	Short expiry date
Barriers
Age	–0.005	0.019	–0.0002	0.014	0.013	0.010	0.007
95% CI	–0.021 to 0.011	0.003 to 0.035	–0.017 to 0.016	–0.002 to 0.031	–0.002 to 0.0295	–0.006 to 0.0265	–0.008 to 0.022
P value	0.513	0.018*	0.977	0.079	0.094	0.222	0.391
Sex	0.033	–0.08	–0.353	–0.128	–0.296	–0.325	–0.267
95% CI	–0.344 to 0.411	–0.449 to 0.293	–0.731 to 0.025	–0.508 to 0.252	–0.665 to 0.072	–0.703 to 0.052	–0.650 to 0.114
P value	0.862	0.679	0.067	0.509	0.115	0.092	0.170
Urban vs rural setting	0.278	–0.291	0.260	–0.069	–0.378	–0.352	–0.265
95% CI	–0.643 to 0.086	–0.648 to 0.065	–0.625 to 0.105	–0.431 to 0.292	–0.737 to -0.019	–0.715 to 0.011	–0.624 to 0.093
P value	0.134	0.109	0.163	0.707	0.039*	0.057	0.147
Years practicing as pharmacist	–0.002	0.013	0.006	0.015	0.015	0.015	0.013
95% CI	–0.018 to 0.013	–0.002 to 0.028	–0.010 to 0.021	–0.001 to 0.031	–0.0003 to 0.031	–0.0003 to 0.031	–0.002 to 0.028
P value	0.787	0.08	0.481	0.065	0.056	0.055	0.095
Pharmacy owner	0.358	0.637	–0.817	–0.212	0.525	–0.457	–0.448
95% CI	–0.154 to 0.871	0.120 to 1.154	–1.350 to 0.285	–0.725 to 0.299	0.010 to 1.040	–0.979 to 0.065	–0.950 to 0.054
P value	0.171	0.016*	0.003*	0.416	0.046*	0.086	0.080

*Statistically significant.